ABVC Receives US$250,000 From ForSeeCon; Vitargus(R) Total Licensing Fee up to US$33.5 Million; US$816,000 Already Received

About this update from Abvc Biopharma, Inc.

[{"type":"image","caption":"","headline":"ABVC BioPharma Highlights Safety Profile of Its Plant-Based ADHD Candidate Amid Growing Concerns About Psychiatric Polypharmacy in the United States","size":{"original":{"width":140,"height":78,"url":"https://media.zenfs.com/en/newsmediawire_165/abacbb2aeeae890aef297a130fea97c7"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/X_qKvHxujBtXyrHhszohog--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIxMDtoPTExNztjZj13ZWJw/https://media.zenfs.com/en/newsmediawire_165/abacbb2aeeae890aef297a130fea97c7","width":140,"height":78}}},{"type":"text","content":"SILICON VALLEY, CA - November 21, 2025 (NEWMEDIAWIRE) - ABVC BioPharma, Inc. ("ABVC" or the "Company") (NASDAQ: ABVC) announced today that ForSeeCon Eye Corporation ("ForSeeCon") has made an additional US$250,000 payment under the existing ophthalmic medical device licensing agreement (the "Licensing Agreement"). To date, ABVC has received US$816,000 in total payments from ForSeeCon in connection with the Licensing Agreement.","length":469,"tagName":"p"},{"type":"text","content":"Licensing Deal Summary","length":22,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"style":"width:139.5pt;border:solid #BFBFBF 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;","val":[{"type":"text","content":"Item","length":4,"tagName":"p"}]},{"style":"width:264.95pt;border:solid #BFBFBF 1.0pt;border-left:none;padding:0cm 5.4pt 0cm 5.4pt;","val":[{"type":"text","content":"Description","length":11,"tagName":"p"}]},{"style":"border:solid #BFBFBF 1.0pt;border-left:none;padding:0cm 5.4pt 0cm 5.4pt;","val":[{"type":"text","content":"Amount","length":6,"tagName":"p"}]}]},{"val":[{"style":"width:139.5pt;border:solid #BFBFBF 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;","val":[{"type":"text","content":"Upfront Payment","length":15,"tagName":"p"}]},{"style":"width:264.95pt;border-top:none;border-left:none;border-bottom:solid #BFBFBF 1.0pt;border-right:solid #BFBFBF 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;","val":[{"type":"text","content":"5,000,000 ForSeeCon shares at US$6 per share[1]","length":47,"tagName":"p"}]},{"style":"border-top:none;border-left:none;border-bottom:solid #BFBFBF 1.0pt;border-right:solid #BFBFBF 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;","val":[{"type":"text","content":"US$30,000,000","length":13,"tagName":"p"}]}]},{"val":[{"style":"width:139.5pt;border:solid...

More updates from Abvc Biopharma, Inc.